Current Radiopharmaceuticals

Review Article

The Production of Ac-225

, 11(3): 173 - 179

Jonathan W. Engle*

DOI: 10.2174/1874471011666180418141357

Review Article

NorthStar Perspectives for Actinium-225 Production at Commercial Scale

, 11(3): 180 - 191

James T. Harvey*

DOI: 10.2174/1874471011666180515123848

Review Article

Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies

, 11(3): 192 - 199

Joseph G. Jurcic*

DOI: 10.2174/1874471011666180525102814

Review Article Open Access

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

, 11(3): 200 - 208

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer

DOI: 10.2174/1874471011666180502104524

Review Article

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

, 11(3): 209 - 214

George Sgouros*, Robert Hobbs and Anders Josefsson

DOI: 10.2174/1874471011666180426130058

Articles Ahead of Print

[⁶⁸Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications

Elisabetta Giovannini, Giampiero Giovacchini, Elisa Borsò, Patrizia Lazzeri, Mattia Riondato, Rossella Leoncini, Valerio Duce and Andrea Ciarmiello*

Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level

Ingrid Kreimerman, Erick Mora-Ramirez , Laura Reyes, Manuel Bardiès, Eduardo Savio * and Henry Engler

Synthesis of Deuterium Labeled 5, 5-Dimethyl-3-(α, α, α-trifluoro-4-nitrom- tolyl) Hydantoin

R Sekhar Bolla, N Murthy Gandikota and I V Kasi Viswanath*

Biochemical and Histopathological Evaluation of the Radioprotective Effects of Melatonin Against Gamma Ray-Induced Skin Damage

Dheyauldeen Shabeeb, Masoud Najafi, Ahmed Eleojo Musa, Mansoor Keshavarz, Alireza Shirazi, Gholamreza Hassanzadeh, Mohammed Reza Hadian and Hedayat Samandari

Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective

Omer Sager*, Ferrat Dincoglan, Selcuk Demiral, Bora Uysal, Hakan Gamsiz, Yelda Elcim, Esin Gundem, Bahar Dirican and Murat Beyzadeoglu

Synthesis of [18F]FAZA Using Nosyl and Iodo Precursors for Nucleophilic Radiofluorination

William Sun, Cheryl Falzon, Ebrahim Naimi , Ali Akbari , Leonard I Wiebe*, Manju Tandon and Piyush Kumar

Determination of Gamma Camera’s Calibration Factors for Quantitation of Diagnostic Radionuclides in Simultaneous Scattering and Attenuation Correction

Afrouz Asgari, Mansour Ashoor, Leila Sarkhosh, Abdollah Khorshidi* and Parvaneh Shokrani

Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal Hemorrhage

Pierpaolo Alongi*, Ignazio Gaspare Vetrano, Elisa Fiasconaro, Valerio Alaimo, Riccardo Laudicella, Marina Bellavia, Francesca Rubino, Sergio Bagnato and Giuseppe Galardi

Evaluating the Radioprotective Effect of Curcumin on Rat’s Heart Tissues

Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli, Masoud Najafi, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa

Abstracts Ahead of Print

Comparison between 18f-Dopa and 18f-Fet Pet/Ct in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and our Experience

Laura Evangelista*, Cuppari Lea, Bellu Luisa , Bertin Daniele, Caccese Mario , Reccia Pasquale, Zagonel Vittorina and Lombardi Giuseppe

O‑(2‑[18F]‑fluoroethyl)-L‑tyrosine (FET) in neurooncology: A review of experimental results

Carina Stegmayr*, Antje Willuweit, Philipp Lohmann and Karl-Josef Langen

Feasibility and evaluation of automated methods for radiolabeling of radiopharmaceutical kits with gallium-68

Alban Revy, François Hallouard*, Sandrine Joyeux-Klamber, Andrea Skanjeti, Catherine Rioufol and Marc Fraysse

[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, in Silico, in Vitro and in Vivo Evaluations.

Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martónez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martónez, Luis A. Espinosa-Rodróguez, Henry Engler, Eduardo Savio and Chryslaine Rodróguez-Tanty*

Editor's Choice

The Production of Ac-225

, 2018; 11(3): 173 - 179

Jonathan W. Engle*

DOI: 10.2174/1874471011666180418141357

NorthStar Perspectives for Actinium-225 Production at Commercial Scale

, 2018; 11(3): 180 - 191

James T. Harvey*

DOI: 10.2174/1874471011666180515123848

Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?

, 2018; 11(2): 123 - 129

Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*

DOI: 10.2174/1874471011666180418110206

Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy

, 2018; 11(1): 34 - 45

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa

DOI: 10.2174/1874471011666171229123130

Personalized & Precision Medicine in Cancer: A Theranostic Approach

, 2017; 10(3): 166 - 170

Partha Choudhury* and Manoj Gupta

DOI: 10.2174/1874471010666170728094008

PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives

, 2017; 10(3): 184 - 194

Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*

DOI: 10.2174/1874471010666170816125051

β -[¹⁸F]Fluoro Azomycin Arabinoside (β -[¹⁸F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors

, 2017; 10(2): 93 - 101

Piyush Kumar*, Peter Roselt, Gerald Reischl, Carlene Cullinane, Davood Beiki, Walter Ehrlichmann, David Binns, Ebrahim Naimi, Jennifer Yang, Rodney Hicks, Hans-Juergen Machulla and Leonard I. Wiebe

DOI: 10.2174/1874471010666170313120540

Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders

, 2017; 10(2): 115 - 122

Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer

DOI: 10.2174/1874471010666170621122221

177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma

, 2017; 10(1): 21 - 28

Ximena Camacho, Victoria Calzada, Marcelo Fernandez, Omar Alonso, Roger Chammas, Eloisa Riva, Juan Pablo Gambini and Pablo Cabral

DOI: 10.2174/1874471009666161010155246

Radiolabeled Sugars Used for PET and SPECT Imaging

, 2016; 9(3): 180 - 186

Brianda Barrios-Lopez and Kim Bergstrom

DOI: 10.2174/1874471008666150525104725

Open Access Articles

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

, 2018; 11(3): 200 - 208

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer

NorthStar Perspectives for Actinium-225 Production at Commercial Scale

, 2018; 11(3): 180 - 191

James T. Harvey*

The Production of Ac-225

, 2018; 11(3): 173 - 179

Jonathan W. Engle*

Development of ²²⁵Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156 - 172

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*

Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level

, 2018; 11: 1 - 9 (E-Pub Ahead of Print)

Ingrid Kreimerman, Erick Mora-Ramirez , Laura Reyes, Manuel Bardiès, Eduardo Savio * and Henry Engler

Synthesis of [18F]2B-SRF101: A Sulfonamide Derivative of the Fluorescent Dye Sulforhodamine 101

, 2017; 10(3): 212 - 220

Ingrid Kreimerman, Williams Porcal, Silvia Olivera, Patricia Oliver, Eduardo Savio* and Henry Engler

Automated One-pot Radiosynthesis of [11C]S-adenosyl Methionine

, 2017; 10(3): 203 - 211

Florencia Zoppolo, Williams Porcal, Patricia Oliver, Eduardo Savio* and Henry Engler

Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders

, 2017; 10(2): 115 - 122

Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer

Gallium-68 in Medical Imaging

, 2016; 9(3): 187 - 207

Lucia Martiniova, Louis De Palatis, Elba Etchebehere and Gregory Ravizzini

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

, 2013; 6(1): 20 - 27

Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle

Targeted α-Particle Therapy: A Clinical Overview

, 2008; 1(3): 251 - 253

Massimo Salvatori, Luca Indovina and Luigi Mansi

Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

, 2008; 1(3): 203 - 208

Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen

Increased [11C]Choline Uptake in Bronchioloalveolar Cell Carcinoma with Negative [18F]FDG Uptake. A PET/CT and Pathology Study

, 2008; 1(2): 62 - 64

Maria Picchio, C. Messa, B. Giglioni, F. Sanvito, E. Caporizzo, C. Landoni, G. Arrigoni, A. Carretta, R. Nicoletti, P. Zannini, A. Del Maschio and F. Fazio

Asymmetric Synthesis of L-[3-13C]Tryptophan

, 2008; 1(2): 122 - 124

Kazuhiko Takatori, Myonghui Lee and Masahiro Kajiwara

Synthesis of 1-Amino-2-[3-13C]propanol Hydrochloride: Completion of Synthetic Methods for all of its 13C- and 15N-Isotopomers

, 2008; 1(2): 120 - 121

K. Iida, Y. Nakajima and M. Kajiwara

Most Cited Articles

Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody

, 2016; 9(1): 44-53.

Shankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S. Jhanwar, Gurveen Kaur, Scott T. Tagawa, David M. Nanus, Neil H. Bander and Stanley J. Goldsmith

DOI: 10.2174/1874471008666150313114005

Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with ¹⁷⁷Lu and Conjugated to Peptides

, 2015; 8(2): 150-159.

Guillermina Ferro-Flores, Blanca E. Ocampo-García, Clara L. Santos-Cuevas, Flor de María Ramírez, Erika P. Azorín-Vega and Laura Meléndez-Alafort

DOI: 10.2174/1874471008666150313115423

Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine

, 2015; 8(2): 78-85.

Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp

DOI: 10.2174/1874471008666150312155959

Indirect Production of No Carrier Added (NCA) ¹⁷⁷Lu from Irradiation of Enriched ¹⁷⁶Yb: Options for Ytterbium/Lutetium Separation

, 2015; 8(2): 107-118.

Ashutosh Dash, Rubel Chakravarty, Furn F. (Russ) Knapp and Ambikalmajan M.R. Pillai

DOI: 10.2174/1874471008666150312161942

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

, 2016; 9(1): 6-7.

Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp

DOI: 10.2174/187447100901151123124826

Theranostic Applications of Lutetium-177 in Radionuclide Therapy

, 2016; 9(1): 94-101.

Tapas Das and Sharmila Banerjee

DOI: 10.2174/1874471008666150313114644

Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176

, 2015; 8(2): 95-106.

Valery A. Tarasov, Oleg I. Andreev, Evgeny G. Romanov, Rostislav A. Kuznetsov, Vladimir V. Kupriyanov and Ivan V. Tselishchev

DOI: 10.2174/1874471008666150312160855

Overview of Development and Formulation of ¹⁷⁷Lu-DOTA-TATE for PRRT

, 2016; 9(1): 8-18.

Wouter A.P. Breeman, Ho Sze Chan, Rory M.S. de Zanger, Mark K. Konijnenberg and Erik de Blois

DOI: 10.2174/1874471008666150313111131

Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT

, 2015; 8(1): 19-31.

Finn Edler von Eyben, Kalevi Kairemo, Timo Kiljunen and Timo Joensuu

DOI: 10.2174/1874471008666150316222203

Evaluation of a Labelled Bacteriophage with 99mTc as a Potential Agent for Infection Diagnosis

, 2016; 9(2): 137-142.

María Elena Cardoso, Leticia Fernández, Emilia Tejería, Patricia Esperón and Mariella Terán

DOI: 10.2174/1874471009666160215162023

Most Accessed Articles

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

, 2018; 11(3): 200-208.

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer

DOI: 10.2174/1874471011666180502104524

Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma

, 2018; 11(1): 14-21.

Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*

DOI: 10.2174/1874471011666171215093112

Development of ²²⁵Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156-172.

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*

DOI: 10.2174/1874471011666180416161908

Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy

, 2018; 11(1): 34-45.

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa

DOI: 10.2174/1874471011666171229123130

PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications

, 2018; 11(1): 4-13.

Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello

DOI: 10.2174/1874471010666171101121803

Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer–A Single Institution Experience

, 2018; 11(2): 147-152.

Kalevi Kairemo, Denai R. Milton, Elba Etchebehere, Eric M. Rohren and Homer A. Macapinlac*

DOI: 10.2174/1874471011666180629145030

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

, 2018; 11(3): 209-214.

George Sgouros*, Robert Hobbs and Anders Josefsson

DOI: 10.2174/1874471011666180426130058

NorthStar Perspectives for Actinium-225 Production at Commercial Scale

, 2018; 11(3): 180-191.

James T. Harvey*

DOI: 10.2174/1874471011666180515123848

Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings

, 2018; 11(1): 22-33.

Giulia Anna Follacchio*, Maria Silvia De Feo, Giuseppe De Vincentis, Francesco Monteleone and Mauro Liberatore

DOI: 10.2174/1874471011666171211161851